• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化用于诊断先天性蔗糖-异麦芽糖酶缺乏症的蔗糖挑战症状测试。

The sucrose challenge symptoms test optimized for diagnosis of congenital sucrase isomaltase deficiency.

机构信息

QOL Medical LLC, Vero Beach, Florida, United States of America.

University of Texas Health Science Center, Houston, Texas, United States of America.

出版信息

PLoS One. 2024 Sep 18;19(9):e0310705. doi: 10.1371/journal.pone.0310705. eCollection 2024.

DOI:10.1371/journal.pone.0310705
PMID:39292728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11410207/
Abstract

BACKGROUND

Congenital sucrase isomaltase deficiency (CSID), an inherited carbohydrate malabsorption disorder, is difficult to diagnose because of overlapping symptoms with other gastrointestinal (GI) diseases. An at-home study was conducted in CSID and healthy adults to evaluate the diagnostic utility of self-reported GI symptoms following administration of a sucrose challenge.

METHODS

This study investigated the optimum symptom scoring with a sucrose challenge symptoms test (SCST) for diagnosing CSID in 45 confirmed patients and 118 healthy controls. Subjects self-reported the severity of GI symptoms using a 10-point Likert scale after ingesting 50 grams of sucrose on an empty stomach. The receiver operator characteristics curve (ROC) was used to identify the diagnostic variable with the highest Youden Index, a measure of diagnostic performance.

RESULTS

All six symptoms were significantly worse in the CSID group within 2 hours after the sucrose challenge. The diagnostic variable with the highest Youden Index was worsening in global symptoms scores at 1- and 2-hours (11.7 [CSID] vs 3.2 [Controls]; P<0.001.) Optimized by gender, the sensitivity and specificity for this diagnostic variable were 87% and 81%, respectively.

CONCLUSIONS

The SCST is a simple, non-invasive at-home test that can aid in a CSID diagnosis.

摘要

背景

先天性蔗糖-异麦芽糖酶缺乏症(CSID)是一种遗传性碳水化合物吸收不良疾病,由于与其他胃肠道(GI)疾病的症状重叠,因此难以诊断。在 CSID 和健康成年人中进行了一项家庭研究,以评估在给予蔗糖挑战后自我报告的胃肠道症状在诊断 CSID 中的效用。

方法

本研究通过蔗糖挑战症状测试(SCST)对 45 名确诊患者和 118 名健康对照者进行了研究,以评估蔗糖挑战后最佳症状评分是否有助于诊断 CSID。受试者在空腹状态下摄入 50 克蔗糖后,使用 10 分制 Likert 量表自我报告胃肠道症状的严重程度。使用受试者工作特征曲线(ROC)确定具有最高 Youden 指数的诊断变量,这是衡量诊断性能的指标。

结果

在蔗糖挑战后 2 小时内,所有 6 种症状在 CSID 组中均明显恶化。具有最高 Youden 指数的诊断变量是在 1 小时和 2 小时时全球症状评分恶化(11.7 [CSID] vs 3.2 [对照组];P<0.001)。通过性别优化后,该诊断变量的灵敏度和特异性分别为 87%和 81%。

结论

SCST 是一种简单、非侵入性的家庭测试,可以辅助 CSID 诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e174/11410207/2bff22aaef59/pone.0310705.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e174/11410207/2bff22aaef59/pone.0310705.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e174/11410207/2bff22aaef59/pone.0310705.g001.jpg

相似文献

1
The sucrose challenge symptoms test optimized for diagnosis of congenital sucrase isomaltase deficiency.优化用于诊断先天性蔗糖-异麦芽糖酶缺乏症的蔗糖挑战症状测试。
PLoS One. 2024 Sep 18;19(9):e0310705. doi: 10.1371/journal.pone.0310705. eCollection 2024.
2
Congenital sucrase-isomaltase deficiency in Türkiye; a single center experience.土耳其先天性蔗糖-异麦芽糖酶缺乏症:单中心经验。
Scand J Gastroenterol. 2024 Jun;59(6):647-651. doi: 10.1080/00365521.2024.2324961. Epub 2024 Mar 8.
3
13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients.用于先天性蔗糖酶异麦芽糖酶缺乏症及补充了蔗糖酶患者蔗糖消化的13C呼气试验
J Pediatr Gastroenterol Nutr. 2009 Apr;48(4):412-8. doi: 10.1097/mpg.0b013e318180cd09.
4
The patient journey to diagnosis and treatment of congenital sucrase-isomaltase deficiency.先天性蔗糖-异麦芽糖酶缺乏症的诊断和治疗的患者旅程。
Qual Life Res. 2021 Aug;30(8):2329-2338. doi: 10.1007/s11136-021-02819-z. Epub 2021 Mar 27.
5
13C-Labeled-Starch Breath Test in Congenital Sucrase-isomaltase Deficiency.先天性蔗糖酶-异麦芽糖酶缺乏症的13C标记淀粉呼气试验
J Pediatr Gastroenterol Nutr. 2018 Jun;66 Suppl 3(Suppl 3):S61-S64. doi: 10.1097/MPG.0000000000001858.
6
Congenital sucrase-isomaltase deficiency: an under-diagnosed disease in Chinese children.先天性蔗糖-异麦芽糖酶缺乏症:中国儿童中一种被低估的疾病。
BMC Pediatr. 2014 Jan 16;14:11. doi: 10.1186/1471-2431-14-11.
7
Evaluation of liquid yeast-derived sucrase enzyme replacement in patients with sucrase-isomaltase deficiency.蔗糖酶-异麦芽糖酶缺乏症患者中液体酵母衍生蔗糖酶的酶替代治疗评估。
Gastroenterology. 1993 Oct;105(4):1061-8. doi: 10.1016/0016-5085(93)90950-h.
8
Differential Effects of Sucrase-Isomaltase Mutants on Its Trafficking and Function in Irritable Bowel Syndrome: Similarities to Congenital Sucrase-Isomaltase Deficiency.肠易激综合征中蔗糖酶-异麦芽糖酶突变体对其运输和功能的差异影响:与先天性蔗糖酶-异麦芽糖酶缺乏的相似性。
Nutrients. 2020 Dec 22;13(1):9. doi: 10.3390/nu13010009.
9
Diagnosing sucrase-isomaltase deficiency: a comparison of a C-sucrose breath test and a duodenal enzyme assay.诊断蔗糖-异麦芽糖酶缺乏症:C-蔗糖呼气试验与十二指肠酶测定的比较。
Scand J Clin Lab Invest. 2024 Jul;84(4):268-272. doi: 10.1080/00365513.2024.2377960. Epub 2024 Jul 10.
10
Molecular pathogenicity of novel sucrase-isomaltase mutations found in congenital sucrase-isomaltase deficiency patients.新型蔗糖酶-异麦芽糖酶突变的分子发病机制,这些突变存在于先天性蔗糖酶-异麦芽糖酶缺乏症患者中。
Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):817-826. doi: 10.1016/j.bbadis.2016.12.017. Epub 2017 Jan 3.

本文引用的文献

1
Carbohydrate Intolerance and Disaccharidase Measurement - a Mini-Review.碳水化合物不耐受与双糖酶检测——一篇综述短文
Clin Biochem Rev. 2019 Nov;40(4):167-174. doi: 10.33176/AACB-19-00025.
2
Diagnostic Utility of Carbohydrate Breath Tests for SIBO, Fructose, and Lactose Intolerance.碳水化合物呼吸试验对 SIBO、果糖和乳糖不耐受的诊断价值。
Dig Dis Sci. 2020 May;65(5):1405-1413. doi: 10.1007/s10620-019-05889-9. Epub 2019 Oct 15.
3
Sucrase-Isomaltase Deficiency as a Potential Masquerader in Irritable Bowel Syndrome.蔗糖-异麦芽糖酶缺乏症:可能是肠易激综合征的伪装者。
Dig Dis Sci. 2020 Feb;65(2):534-540. doi: 10.1007/s10620-019-05780-7. Epub 2019 Sep 6.
4
Clinical and Histopathologic Predictors of Disaccharidase Deficiency in Duodenal Biopsy Specimens.十二指肠活检标本中双糖酶缺乏的临床和组织病理学预测因子。
Am J Clin Pathol. 2019 Nov 4;152(6):742-746. doi: 10.1093/ajcp/aqz091.
5
Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients.肠易激综合征患者中罕见的蔗糖-异麦芽糖酶病 因变异的流行率增加。
Clin Gastroenterol Hepatol. 2018 Oct;16(10):1673-1676. doi: 10.1016/j.cgh.2018.01.047. Epub 2018 Feb 21.
6
Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.胃肠道疾病中基于氢气和甲烷的呼气测试:北美共识
Am J Gastroenterol. 2017 May;112(5):775-784. doi: 10.1038/ajg.2017.46. Epub 2017 Mar 21.
7
Disaccharidase activity in children undergoing esophagogastroduodenoscopy: A systematic review.接受食管胃十二指肠镜检查的儿童的双糖酶活性:一项系统评价。
World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):283-93. doi: 10.4292/wjgpt.v7.i2.283.
8
Clinical aspects and treatment of congenital sucrase-isomaltase deficiency.先天性蔗糖酶-异麦芽糖酶缺乏症的临床特点与治疗
J Pediatr Gastroenterol Nutr. 2012 Nov;55 Suppl 2:S7-13. doi: 10.1097/01.mpg.0000421401.57633.90.
9
How to interpret hydrogen breath tests.如何解读氢呼气试验
J Neurogastroenterol Motil. 2011 Jul;17(3):312-7. doi: 10.5056/jnm.2011.17.3.312. Epub 2011 Jul 14.
10
Breath tests for gastrointestinal disease: the real deal or just a lot of hot air?用于胃肠疾病的呼气试验:是真有效果还是只是空谈?
Gastroenterology. 2007 Dec;133(6):1763-6. doi: 10.1053/j.gastro.2007.10.059.